2 recruiting, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow cyclopropapyrroloindole: new trials by email Literature Review of cyclopropapyrroloindole trials Research Report on cyclopropapyrroloindole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer BC1 cell line, Bria-OTS regimen and CPI (tislelizumab), Bria-OTS regimen and CPI (tislelizumab) expansion cohort - Breast Cancer, Breast Tumor | Phase 1 / Phase 2 | Unknown | BriaCell Therapeutics Corporation | 18 | 2024-05-29 | 2024-08-26 |
| Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs Injection of drug-eluting microspheres with multiple drugs into solid tumors - Hepatocellular Carcinoma, Solid Tumor, Adult | Phase 2 | Recruiting | Second Affiliated Hospital of Guangzhou Medical University | 100 | 2020-11-01 | 2024-08-21 |
| Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy - Hepatocarcinoma, Lung Cancer | Phase 2 / Phase 3 | Recruiting | Second Affiliated Hospital of Guangzhou Medical University | 200 | 2018-11-01 | 2024-06-25 |
Breast Neoplasms (2) · Carcinoma, Hepatocellular (2) · Lung Neoplasms (2) · Colonic Neoplasms (1) · Head and Neck Neoplasms (1) · Kidney Neoplasms (1) · Melanoma (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Uterine Cervical Neoplasms (1)
Second Affiliated Hospital of Guangzhou Medical University (2) · BriaCell Therapeutics Corporation (1)
China (2) · United States (1)
Giuseppe Del Priore, MD, MPH (1) · Victoria Chua-Alcala, MD (1) · Zhenfeng Zhang, MD, PhD (1) · Zhenfeng Zhang, MD,PhD (1)